Abstract:BACKGROUND:The blood-brain barrier (BBB) maintains the balance of the internal environment of the brain and strictly controls substance exchange between the brain and blood dynamically but stably. Transient increases in the permeability of the BBB plays an important role in helping macromolecular drugs enter the brain to exert their pharmacological effects. Previous research has revealed that electronic acupuncture (EA) stimulation connecting Baihui (GV20) and Shuigou (GV26) at a specific frequency can enhance the permeability of the BBB at 8 minutes after the intervention and induce the entry of 20 kDa fluorescein isothiocyanate-dextran (FITC-dextran) into the cerebral cortex, but whether it can also allow drugs to pass the BBB remains unknown. We hypothesized that EA at a specific frequency could open the BBB and induce the entry of nerve growth factor (NGF) into the brain to exert its therapeutic effect.METHODS:First, the middle cerebral artery occlusion (MCAO) model is adopted and changes in the permeability and structure of the BBB are assessed by measuring both the intensity of Evans blue (EB) staining and the cerebral infarction volume, and by evaluating the ultrastructure of the BBB. Then, a laser spectrometer and immunofluorescence are used to observe entry of NGF into the brain. Finally, the learning and memory ability of rats are assessed and the DeadEndTM Fluorometric TUNEL System is applied to assess apoptosis in the hippocampus.RESULTS:Our results showed that, in the first, the BBB was essentially repaired three weeks after MCAO operation. Secondly, Electronic Acupuncture (EA) stimulation at a specific frequency can enhance BBB permeability in the prefrontal cortex and induce NGF uptake by prefrontal neurons. Finally, in the presence of EA stimulation, entry of NGF into the brain promoted learning and memory in rats and inhibited the apoptosis of neurons in the hippocampus.CONCLUSIONS:In this study, the timing of BBB repair in the MCAO model was determined under pathological conditions and the EA stimulation can induce the entry of NGF into the brain to exert its therapeutic effect. EA could serve as a new strategy for delivering therapeutics to the central nervous system (CNS), given that EA stimulation at a specific frequency was shown to increase the permeability of the BBB. Further study of the mechanism underlying the opening of the BBB and its timing is needed.

Research progress of neurotrophic factors and blood-brain barrier

The Mechanism and Latest Research Progress of Blood–Brain Barrier Breakthrough

The Influence of Electronic Acupuncture at A Specific Frequency in Facilitating the Passage of NGF Through the Blood-Brain Barrier and Its Effect on Learning and Memory in MCAO/R Rats

Research progress in cellular and molecular mechanisms related to permeability alteration of blood-brain barrier

Recent progress in studies of neurotrophic factors and their clinical implications

Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides

Nanocarriers As a Powerful Vehicle to Overcome Blood-Brain Barrier in Treating Neurodegenerative Diseases: Focus on Recent Advances

Resea Rch Progress of Multiple Neuroprotective Effects of Brain-Derived Neurotrophic Factor after Central Nervous System Injury and Its Mechanism

Factors Influencing the Blood-Brain Barrier Permeability

Research Progress on the Strategies for Crossing the Blood-Brain Barrier

New advances in diagnosis and treatment of nano drug delivery systems across the blood-brain barrier

Research Progress of Brain Ischemic Injury Protective Agents

Pathological opening of blood-brain barrier in disease conditions

The blood–brain barrier: structure, regulation, and drug delivery

Research Progress on Natural Plant Molecules in Regulating the Blood–Brain Barrier in Alzheimer’s Disease

Advancements in strategies for overcoming the blood-brain barrier to deliver brain-targeted drugs

Blood-brain barrier disruption following brain injury: Implications for clinical practice

Research Progress on Neuroprotection and Neurotoxicity of NMDA Receptor Antagonist

Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models

Vascular Endothelial Growth Factor: from Angiogenesis to Neuroprotection

Recent advances in tissue repair of the blood-brain barrier after stroke